"Bridge" Fewer Warfarin Patients With Enoxaparin
You'll see LESS use of "bridging" with low-molecular-weight heparin (enoxaparin, etc) in warfarin patients.
Up to 1 in 6 patients are bridged with an injectable anticoagulant when warfarin is temporarily stopped before surgery or a procedure...hoping to prevent thrombosis or stroke.
But evidence from the new BRIDGE trial will be a game changer. It suggests that bridging does more harm than good in many patients.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote